Dry eye relief for acne patients on isotretinoin
Part of Skin clinical trials.
This trial tests a treatment for dry eyes caused by isotretinoin, a drug used for severe acne. It aims to help people with moderate to severe acne who are already taking isotretinoin and experiencing dry eye symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe acne
- You are currently taking isotretinoin
- You do not have other eye diseases that cause dry eyes
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.
This study compares two different dosages of isotretinoin (a powerful acne medication) to see which works better and causes fewer side effects. Isotretinoin is typically used for acne that hasn't improved with other treatments.
This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.
This trial tests a medical device eye ointment called Vit-A-Vision for people with dry eye disease. It aims to see if the ointment can improve symptoms and tear film stability over about a month.
This study tests whether TearCare, a device that warms and massages the eyelids, can help young adults with dry eyes caused by blocked oil glands. The trial measures whether the treatment improves tear quality and eye comfort.
This trial tests a new eye drop, Drop 0.4%, for people with dry eye. It includes both people who wear contact lenses and those who don’t, to see if the drop is safe and helps with symptoms.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.